An easier prescription

July 7, 2017 by Hannah Diorio-Toth
Credit: Pixabay

Type I diabetes patients typically inject insulin several times a day, a painful process that reduces quality-of-life. Injectable medications are also associated with noncompliance, which can result in long-term complications for patients with chronic disease and dramatic increases in healthcare costs.

So, what's holding doctors back from prescribing a far simpler solution, like an insulin pill? Our own digestion systems are to blame—because in this case, they function too well for their own good.

"Our bodies see any proteins that we ingest as food, even if this is a therapeutic drug like insulin. Proteins that enter the stomach are digested into individual amino acids and lose any intended therapeutic function," explains Katie Whitehead, assistant professor of chemical engineering at Carnegie Mellon University.

Even if the drug was somehow able to make the journey to the small intestine without being digested, our body still wouldn't be able to absorb it. Large protein drugs do not permeate the intestinal lining, which means it is impossible for the drug to move into the bloodstream and start to work in the body.

Whitehead saw this drug delivery challenge as an opportunity to join forces with colleague Alan Russell, professor and director of the Disruptive Health Technology Institute. With Whitehead's background in and Russell's expertise in -based protein engineering, the team developed a novel solution. Their research was recently published in The Journal of Controlled Release.

Credit: Carnegie Mellon University College of Engineering

Using a technique called Atom Transfer Radical Polymerization (ATRP) (which was developed at Carnegie Mellon by chemistry professor Krzysztof Matyjaszewski), the team created a packaged protein that survives digestion-like conditions and is easily transported across the intestinal barrier in a cell culture . The protein used in this study served as a model for therapeutic drugs such as insulin.

ATRP allowed Russell to attach a polymer to the model protein. Once attached, this polymer acted as a shield against digestive enzymes in the stomach.

"Our team had developed a polymer that was very stable, enough that it would survive in hydrochloric acid," says Russell. "We felt confident that we could use this polymer to protect the model protein from the stomach, but the second challenge remained of selectively moving the model protein through the intestinal wall."

To tackle this challenge, Whitehead identified a chemical structure called phenylpiperazine that increases the permeability of the intestine. By surrounding the protein in a polymer made from phenylpiperazine, the model protein easily passed across intestinal cell barriers. Notably, the research team increased the transport of the model protein without increasing the transport of other harmful compounds, such as waste products, across the intestine.

"We are excited about this research because we have demonstrated that polymer conjugation can be used to achieve oral protein delivery. These findings give rise to many more questions that we look forward to tackling, such as how the polymer structure and architecture influence the delivery process as well as whether these results translate in vivo," says Whitehead.

This project is thought by the researchers to be an important introductory step in their research towards developing oral delivery systems that can be tested and used clinically.

Explore further: Investigating folding stability and dynamics of proteins

More information: Chad S. Cummings et al, ATRP-grown protein-polymer conjugates containing phenylpiperazine selectively enhance transepithelial protein transport, Journal of Controlled Release (2017). DOI: 10.1016/j.jconrel.2017.04.035

Related Stories

Investigating folding stability and dynamics of proteins

July 5, 2017

Hydrogels are polymer materials that can absorb a large amount of water, making them flexible like human tissue. They are used in a number of medical applications, including contact lenses, wound dressings, and facial reconstruction.

How does your immune system react to nanomedicine?

October 4, 2016

Katie Whitehead, assistant professor of chemical engineering at Carnegie Mellon University, has focused her research efforts on two clear objectives: treating and preventing disease. Her clinical-minded approach to laboratory ...

Insulin pill could make diabetes treatment 'ouchless'

August 24, 2016

Every day, millions of Americans with diabetes have to inject themselves with insulin to manage their blood-sugar levels. But less painful alternatives are emerging. Scientists are developing a new way of administering the ...

Recommended for you

The birth of a new protein

October 20, 2017

A yeast protein that evolved from scratch can fold into a three-dimensional shape—contrary to the general understanding of young proteins—according to new research led by the University of Arizona.

Discovery lights path for Alzheimer's research

October 19, 2017

A probe invented at Rice University that lights up when it binds to a misfolded amyloid beta peptide—the kind suspected of causing Alzheimer's disease—has identified a specific binding site on the protein that could facilitate ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

jimbolea1
not rated yet Jul 07, 2017
Being a type 1 diabetic for 35 years. please let this dream come true.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.